In Vivo - Strategic Analysis For Medtech And Pharma Leaders since 1981

Podcasts


Innovation


Insilico Medicine’s Precious3GPT Advances AI For Longevity

 
• By 

InSilico Medicine hopes its open-source LLM will be the “one model to guide them all” as industry moves towards artificial biomedical intelligence and interest in longevity grows.

How To Create Organizational Readiness for AI

 
• By 

The time is now to prepare your company for AI implementation. Doing so starts with the C-suite.

Market Access


Amgen’s Surprise Aflibercept Launch Shakes Up US Biosimilars In 2024

 
• By 

As the US biosimilars market approaches the end of its first decade, it has seen another busy year, with Amgen’s surprise launch of a rival to Eylea shaking up expectations as other first-time approvals rolled in throughout 2024. Meanwhile, competition to Stelara is waiting in the wings from the start of 2025.